BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Policy

  Pfizer Inc. (JOBS) Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial

  September 9, 2008

   · 

  3 min read
• Drug Development

  FluoroPharma to Report Preclinical Data on Alzheimer’s Disease and Prostate Cancer PET Imaging Agents

  September 9, 2008

   · 

  3 min read
• Drug Development

  Omeros Corporation Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302

  September 9, 2008

   · 

  2 min read
• Drug Development

  Novartis AG (JOBS) Cancer Drug Wins U.S. Priority Review

  September 9, 2008

   · 

  6 min read
• Pharm Country

  Mylan Inc. to Offer $400 Million in Cash Convertible Notes

  September 9, 2008

   · 

  3 min read
• Business

  Metabasis Therapeutics, Inc. Appoints Dr. Molly Holman as Vice President of Intellectual Property

  September 9, 2008

   · 

  1 min read
• Pharm Country

  Proscape Technologies Announces the First Annual Closed Loop Marketing Executive Summit, Featuring Education from Leading Life Sciences Companies, Including AstraZeneca PLC, Johnson & Johnson, Merck & Co., Inc. and Wyeth

  September 9, 2008

   · 

  1 min read
• Genetown

  Bruker BioSciences Corporation to Present at UBS Warburg Global Life Sciences Conference in New York

  September 9, 2008

   · 

  1 min read
• Business

  Compugen Ltd. Retains Porter Novelli Life Sciences for U.S. Corporate Communications Initiative

  September 9, 2008

   · 

  1 min read
• Drug Development

  Cardiovascular BioTherapeutics, Inc. Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial

  September 9, 2008

   · 

  2 min read